CN112746064B - 一种来源于梭菌属的壳聚糖酶基因及其重组菌和在生产壳寡糖上的应用 - Google Patents
一种来源于梭菌属的壳聚糖酶基因及其重组菌和在生产壳寡糖上的应用 Download PDFInfo
- Publication number
- CN112746064B CN112746064B CN202011558290.3A CN202011558290A CN112746064B CN 112746064 B CN112746064 B CN 112746064B CN 202011558290 A CN202011558290 A CN 202011558290A CN 112746064 B CN112746064 B CN 112746064B
- Authority
- CN
- China
- Prior art keywords
- chitosanase
- gene
- chitosan
- enzyme
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010089807 chitosanase Proteins 0.000 title claims abstract description 56
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 title claims abstract description 28
- 241000193403 Clostridium Species 0.000 title claims abstract description 19
- 241000894006 Bacteria Species 0.000 title claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 229920001661 Chitosan Polymers 0.000 claims abstract description 57
- 230000000694 effects Effects 0.000 claims abstract description 40
- 238000006243 chemical reaction Methods 0.000 claims abstract description 30
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 20
- 239000013612 plasmid Substances 0.000 claims abstract description 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 13
- 230000007062 hydrolysis Effects 0.000 claims abstract description 13
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 239000001888 Peptone Substances 0.000 claims description 8
- 108010080698 Peptones Proteins 0.000 claims description 8
- 235000019319 peptone Nutrition 0.000 claims description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 5
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 5
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 60
- 102000004190 Enzymes Human genes 0.000 abstract description 49
- 241000588724 Escherichia coli Species 0.000 abstract description 18
- 229910021645 metal ion Inorganic materials 0.000 abstract description 7
- 238000011160 research Methods 0.000 abstract description 5
- 108010031186 Glycoside Hydrolases Proteins 0.000 abstract description 4
- 102000005744 Glycoside Hydrolases Human genes 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 102000004533 Endonucleases Human genes 0.000 abstract 1
- 108010042407 Endonucleases Proteins 0.000 abstract 1
- 238000005065 mining Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 45
- 239000000243 solution Substances 0.000 description 27
- 239000000047 product Substances 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 241000269331 Ambystoma Species 0.000 description 8
- 239000007974 sodium acetate buffer Substances 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000001976 enzyme digestion Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 241000205573 Jeffersonia Species 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 239000000413 hydrolysate Substances 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229960002442 glucosamine Drugs 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- NTUPOKHATNSWCY-PMPSAXMXSA-N (2s)-2-[[(2s)-1-[(2r)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=CC=C1 NTUPOKHATNSWCY-PMPSAXMXSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 241000220223 Fragaria Species 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- KQNDIKOYWZTZIX-FXQIFTODSA-N Ser-Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KQNDIKOYWZTZIX-FXQIFTODSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006196 deacetylation Effects 0.000 description 2
- 238000003381 deacetylation reaction Methods 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 108010089198 phenylalanyl-prolyl-arginine Proteins 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- WRDANSJTFOHBPI-FXQIFTODSA-N Ala-Arg-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N WRDANSJTFOHBPI-FXQIFTODSA-N 0.000 description 1
- FXKNPWNXPQZLES-ZLUOBGJFSA-N Ala-Asn-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FXKNPWNXPQZLES-ZLUOBGJFSA-N 0.000 description 1
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 1
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
- DQNLFLGFZAUIOW-FXQIFTODSA-N Arg-Cys-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O DQNLFLGFZAUIOW-FXQIFTODSA-N 0.000 description 1
- RFXXUWGNVRJTNQ-QXEWZRGKSA-N Arg-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N RFXXUWGNVRJTNQ-QXEWZRGKSA-N 0.000 description 1
- UHFUZWSZQKMDSX-DCAQKATOSA-N Arg-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UHFUZWSZQKMDSX-DCAQKATOSA-N 0.000 description 1
- GSUFZRURORXYTM-STQMWFEESA-N Arg-Phe-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 GSUFZRURORXYTM-STQMWFEESA-N 0.000 description 1
- HNJNAMGZQZPSRE-GUBZILKMSA-N Arg-Pro-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O HNJNAMGZQZPSRE-GUBZILKMSA-N 0.000 description 1
- XMGVWQWEWWULNS-BPUTZDHNSA-N Arg-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N XMGVWQWEWWULNS-BPUTZDHNSA-N 0.000 description 1
- QMQZYILAWUOLPV-JYJNAYRXSA-N Arg-Tyr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CC1=CC=C(O)C=C1 QMQZYILAWUOLPV-JYJNAYRXSA-N 0.000 description 1
- LFWOQHSQNCKXRU-UFYCRDLUSA-N Arg-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 LFWOQHSQNCKXRU-UFYCRDLUSA-N 0.000 description 1
- IZSMEUDYADKZTJ-KJEVXHAQSA-N Arg-Tyr-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IZSMEUDYADKZTJ-KJEVXHAQSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- JTNKVWLMDHIUOG-IHRRRGAJSA-N Cys-Arg-Phe Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JTNKVWLMDHIUOG-IHRRRGAJSA-N 0.000 description 1
- KCSDYJSCUWLILX-BJDJZHNGSA-N Cys-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N KCSDYJSCUWLILX-BJDJZHNGSA-N 0.000 description 1
- SRIRHERUAMYIOQ-CIUDSAMLSA-N Cys-Leu-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SRIRHERUAMYIOQ-CIUDSAMLSA-N 0.000 description 1
- KVGPYKUIHZJWGA-BQBZGAKWSA-N Cys-Met-Gly Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O KVGPYKUIHZJWGA-BQBZGAKWSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- RGXXLQWXBFNXTG-CIUDSAMLSA-N Gln-Arg-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O RGXXLQWXBFNXTG-CIUDSAMLSA-N 0.000 description 1
- KWUSGAIFNHQCBY-DCAQKATOSA-N Gln-Arg-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O KWUSGAIFNHQCBY-DCAQKATOSA-N 0.000 description 1
- FJAYYNIXQNERSO-ACZMJKKPSA-N Gln-Cys-Asp Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N FJAYYNIXQNERSO-ACZMJKKPSA-N 0.000 description 1
- RGAOLBZBLOJUTP-GRLWGSQLSA-N Gln-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CCC(=O)N)N RGAOLBZBLOJUTP-GRLWGSQLSA-N 0.000 description 1
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 1
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 1
- GTBXHETZPUURJE-KKUMJFAQSA-N Gln-Tyr-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GTBXHETZPUURJE-KKUMJFAQSA-N 0.000 description 1
- VPKBCVUDBNINAH-GARJFASQSA-N Glu-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VPKBCVUDBNINAH-GARJFASQSA-N 0.000 description 1
- RDDSZZJOKDVPAE-ACZMJKKPSA-N Glu-Asn-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDDSZZJOKDVPAE-ACZMJKKPSA-N 0.000 description 1
- MIIGESVJEBDJMP-FHWLQOOXSA-N Glu-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 MIIGESVJEBDJMP-FHWLQOOXSA-N 0.000 description 1
- TWYSSILQABLLME-HJGDQZAQSA-N Glu-Thr-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O TWYSSILQABLLME-HJGDQZAQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 1
- TWTPDFFBLQEBOE-IUCAKERBSA-N Gly-Leu-Gln Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O TWTPDFFBLQEBOE-IUCAKERBSA-N 0.000 description 1
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 1
- IROABALAWGJQGM-OALUTQOASA-N Gly-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)CN IROABALAWGJQGM-OALUTQOASA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- SKYULSWNBYAQMG-IHRRRGAJSA-N His-Leu-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SKYULSWNBYAQMG-IHRRRGAJSA-N 0.000 description 1
- ISQOVWDWRUONJH-YESZJQIVSA-N His-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CN=CN3)N)C(=O)O ISQOVWDWRUONJH-YESZJQIVSA-N 0.000 description 1
- WTOAPTKSZJJWKK-HTFCKZLJSA-N Ile-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N WTOAPTKSZJJWKK-HTFCKZLJSA-N 0.000 description 1
- GQKSJYINYYWPMR-NGZCFLSTSA-N Ile-Gly-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N GQKSJYINYYWPMR-NGZCFLSTSA-N 0.000 description 1
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 1
- COWHUQXTSYTKQC-RWRJDSDZSA-N Ile-Thr-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N COWHUQXTSYTKQC-RWRJDSDZSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 1
- YORLGJINWYYIMX-KKUMJFAQSA-N Leu-Cys-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YORLGJINWYYIMX-KKUMJFAQSA-N 0.000 description 1
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 1
- IWMJFLJQHIDZQW-KKUMJFAQSA-N Leu-Ser-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IWMJFLJQHIDZQW-KKUMJFAQSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- VHNOAIFVYUQOOY-XUXIUFHCSA-N Lys-Arg-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VHNOAIFVYUQOOY-XUXIUFHCSA-N 0.000 description 1
- QQUJSUFWEDZQQY-AVGNSLFASA-N Lys-Gln-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN QQUJSUFWEDZQQY-AVGNSLFASA-N 0.000 description 1
- VWJFOUBDZIUXGA-AVGNSLFASA-N Lys-Val-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCCN)N VWJFOUBDZIUXGA-AVGNSLFASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- WFDAEEUZPZSMOG-SRVKXCTJSA-N Phe-Cys-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O WFDAEEUZPZSMOG-SRVKXCTJSA-N 0.000 description 1
- JXQVYPWVGUOIDV-MXAVVETBSA-N Phe-Ser-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JXQVYPWVGUOIDV-MXAVVETBSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- HQTKVSCNCDLXSX-BQBZGAKWSA-N Ser-Arg-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O HQTKVSCNCDLXSX-BQBZGAKWSA-N 0.000 description 1
- OBXVZEAMXFSGPU-FXQIFTODSA-N Ser-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)CN=C(N)N OBXVZEAMXFSGPU-FXQIFTODSA-N 0.000 description 1
- BLPYXIXXCFVIIF-FXQIFTODSA-N Ser-Cys-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N)CN=C(N)N BLPYXIXXCFVIIF-FXQIFTODSA-N 0.000 description 1
- RNMRYWZYFHHOEV-CIUDSAMLSA-N Ser-Gln-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RNMRYWZYFHHOEV-CIUDSAMLSA-N 0.000 description 1
- YIUWWXVTYLANCJ-NAKRPEOUSA-N Ser-Ile-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YIUWWXVTYLANCJ-NAKRPEOUSA-N 0.000 description 1
- UGTZYIPOBYXWRW-SRVKXCTJSA-N Ser-Phe-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O UGTZYIPOBYXWRW-SRVKXCTJSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- SQHKXWODKJDZRC-LKXGYXEUSA-N Ser-Thr-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQHKXWODKJDZRC-LKXGYXEUSA-N 0.000 description 1
- 241000981897 Streptomyces sp. N174 Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- QNCFWHZVRNXAKW-OEAJRASXSA-N Thr-Lys-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QNCFWHZVRNXAKW-OEAJRASXSA-N 0.000 description 1
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 1
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 1
- XEEHBQOUZBQVAJ-BPUTZDHNSA-N Trp-Arg-Cys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N XEEHBQOUZBQVAJ-BPUTZDHNSA-N 0.000 description 1
- RNFZZCMCRDFNAE-WFBYXXMGSA-N Trp-Asn-Ala Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O RNFZZCMCRDFNAE-WFBYXXMGSA-N 0.000 description 1
- IELISNUVHBKYBX-XDTLVQLUSA-N Tyr-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IELISNUVHBKYBX-XDTLVQLUSA-N 0.000 description 1
- UXUFNBVCPAWACG-SIUGBPQLSA-N Tyr-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N UXUFNBVCPAWACG-SIUGBPQLSA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- CWOSXNKDOACNJN-BZSNNMDCSA-N Val-Arg-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N CWOSXNKDOACNJN-BZSNNMDCSA-N 0.000 description 1
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 1
- RYHUIHUOYRNNIE-NRPADANISA-N Val-Ser-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N RYHUIHUOYRNNIE-NRPADANISA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- MIAZWUMFUURQNP-YDHLFZDLSA-N Val-Tyr-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N MIAZWUMFUURQNP-YDHLFZDLSA-N 0.000 description 1
- IECQJCJNPJVUSB-IHRRRGAJSA-N Val-Tyr-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(O)=O IECQJCJNPJVUSB-IHRRRGAJSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229960001931 ampicillin sodium Drugs 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010038850 arginyl-isoleucyl-tyrosine Proteins 0.000 description 1
- 108010094001 arginyl-tryptophyl-arginine Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010026195 glycanase Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 108010028295 histidylhistidine Proteins 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01132—Chitosanase (3.2.1.132)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种来源于梭菌属的壳聚糖酶基因及其重组菌在生产壳寡糖上的应用。该酶是一种内切酶,来源于糖苷水解酶GH‑46家族,其水解产物聚合度区间为3‑9,主要分布于3‑5,水解效率大于90%。此外,对该酶的基因序列进行对比发现,其与已经报道的壳聚糖酶氨基酸序列最高相似性仅为34.7%。通过酶学性质研究,其最适反应温度为50℃,最适反应pH为6.0,金属离子Mg2+、Mn2+对其活性有促进作用。同时,将编码该壳聚糖酶基因的重组质粒转化至大肠杆菌中,能有效表达并降解壳聚糖。本发明通过将梭菌属中地壳聚糖酶基因重组于大肠杆菌工程菌,获得能够高效表达该基因的重组大肠杆菌工程菌E.coli Trans1‑T1/pTrc99a‑csE,具有较高的经济价值和工业应用前景,为新酶的挖掘与应用拓宽了资源。
Description
技术领域
本发明属于生物工程技术领域,特别涉及一种来源于梭菌属的壳聚糖酶基因,同时还涉及该酶的获取以及重组表达,还涉及该重组菌在生产壳寡糖上的具体应用。
背景技术
壳聚糖(Chitosan,简称CTS)是甲壳素脱N-乙酰基的产物,在自然界中储量丰富,由于具有无毒、良好的生物容性和成膜性等优良特性,在农业、医疗卫生等方面有广泛的用途。但是壳聚糖的分子量大,晶体结构紧密,水溶性较差,在人体内不易被吸收,使其应用开发受到限制。与壳聚糖相比,通过降解壳聚糖获得的壳寡糖(聚合度在20以下),水溶性好,分子量低,容易被生物体吸收利用,具有壳聚糖不可比拟的优越性。由于其独特的功能性质,壳寡糖在废水处理、食品工业、日用化学品、纺织、化工、农业、生物工程和医药等领域均具有广泛的应用前景,是壳聚糖高值化利用的关键环节。
壳聚糖的水解方式一般有化学法、物理法和生物酶法,其中,生物酶法是利用非专一或专一性酶对壳聚糖进行降解产生壳寡糖,具有产物分子量易于控制、反应条件温和、低环境污染等优点。虽然已报道有30多种非专一性酶能降解壳聚糖(如蛋白酶、脂肪酶及纤维素酶等),但这些商品酶制剂大多存在专一性差、酶制剂用量大、水解效率并不高的问题,也尚未被证实是否含壳聚糖酶。而本发明所提供的壳聚糖酶的转化效率经验证均在90%以上。壳聚糖酶(EC3.2.1.132)是一种专一性水解酶,是酶法降解壳聚糖研究的核心。同时,从自然环境中寻找到产壳聚糖酶的新菌株也是壳聚糖应用研究的重要内容。
因此,合理开发从自然界筛选得到的壳聚糖酶新基因,进而对新酶的特性研究并将其应用到实际生产中,解决化学法生产所带来的严重环境问题,将是未来壳寡糖产业的发展方向。
发明内容
本发明所要解决的技术问题是针对壳寡糖现有生产技术的弊端,提供一种来源于梭菌属的壳聚糖酶基因,同时提供一种包括该基因的重组质粒,还提供一种含有该基因的大肠杆菌工程菌及其获取方法。
为了解决上述技术问题,本发明采取的技术方案如下:
一种来源于梭菌属的壳聚糖酶,其氨基酸序列如SEQ ID NO:1所示,其与已经报道的壳聚糖酶氨基酸序列最高相似性仅为34.7%。
编码所述壳聚糖酶的基因,其核苷酸序列如SEQ ID NO:2所示。
一种重组质粒,它包含所述的壳聚糖酶的基因。
一种重组菌,它含有所述的重组质粒。
壳聚糖酶的制备方法,在营养培养基中培养所述的重组菌,收集具有壳聚糖酶活性的多肽。
所述营养培养基为酵母粉5.0-7.5g/L,甘油10.2-12g/L,蛋白胨11.5-15.0g/L,磷酸氢二钾6.3-8.6g/L,磷酸二氢钾1.2-3.0g/L,硫酸镁0.32-0.48g/L,硫酸铵1.2-2.6g/L。
所述壳聚糖酶在生产壳寡糖上的应用。
将壳聚糖酶按照50U/g壳聚糖的添加量直接与底物0.1-8%的胶体壳聚糖溶液反应4-8h,即获得所述壳寡糖。所制备得到的壳寡糖聚合度区间为3-9,主要为3-5。壳寡糖聚合度区间为3-5的占比超过80%。所述反应温度为45-55℃,反应pH为5.0-6.0,优选反应温度为50℃,反应pH为6.0。
反应过程中添加Mg2+、Mn2+进一步提高水解效率。所述Mg2+、Mn2+浓度为1-10mmol/L,所述Mg2+、Mn2+浓度优选为5mmol/L。
应当理解,本领域技术人员可根据本发明公开的氨基酸序列,在不影响其活性的前提下,取代、缺失和/或增加一个或几个氨基酸,得到所述蛋白的突变序列。因此,本发明的壳聚糖酶还包括由SEQ ID No.1所示的氨基酸序列中经取代、缺失或添加一个或几个氨基酸且具有同等活性的由SEQ ID No.1所示的蛋白质衍生的蛋白质。例如通过在末端添加标签序列,如His-tag或Strep-tag而衍生的蛋白质。
优选的,壳聚糖酶的衍生蛋白的氨基酸序列与SEQ ID No.1所示的氨基酸序列的同源性可为70%以上,优选80%以上,更优选90%以上。
本发明还提供的含有所述基因或基因簇的载体、细胞系及宿主菌均属于本发明的保护范围。
本领域技术人员能够理解,作为遗传密码简并性的结果,许多不同的多核苷酸能够编码相同的多肽。另外,应当理解,本领域技术人员能够使用常规的技术进行核苷酸取代,所述取代不会影响本发明中所使用的多核苷酸编码的多肽序列。另外,还可以使用本领域中的已知的方法对多核苷酸进行修饰,以增强本发明多核苷酸在体内的活性或者存活期。
本发明中,可选用本领域己知的各种载体,如质粒,粘粒,噬菌体及反转录病毒等。
重组表达载体可以用本领域熟知的方法导入宿主细胞中,这些方法包括:氯化钙热激法,电转化法,PEG介导法,基因枪法等。
壳聚糖酶基因的获得、重组质粒和重组工程菌的构建:
所述梭菌属,该菌株分离自草莓根际土壤,经16s rDNA鉴定及生理生化指标测定,将该菌株鉴定为梭菌属;根据该菌株测序结果发现其具有潜在的壳聚糖酶基因。通过选用诺维赞的细菌基因组DNA提取试剂盒提取该菌株基因组,经NCBI比对后选用具有高度同源性的壳聚糖酶基因作为目标序列,设计引物csE-F:AGTAAAACAAAGATGAAAAATTTACGA
csF-R:ATAAACATCACCATCATTATTGGGATT
以梭菌属基因组DNA为模板,对其进行目的基因序列csE的扩增,从该菌中获得壳聚糖酶基因片段,其核苷酸序列如SEQ ID NO:2所示。
壳聚糖酶(EC3.2.1.132)是一种糖基水解酶,主要来源于细菌和真菌,以内切方式催化水解部分乙酰化壳聚糖中的β-1,4-氨基葡萄糖苷键,生成壳寡糖。根据氨基酸序列不同,可将壳聚糖酶分为5个糖苷水解酶家族,分别为:GH-5、GH-8、GH-46、GH-75和GH-80。本发明所述壳聚糖酶是属于GH-46家族。
所述壳聚糖酶,其氨基酸序列如SEQ ID NO:1所示,其与已经报道的壳聚糖酶氨基酸序列(来源Streptomyces sp.N174,Uniprot号为P33665)最高相似性为34.7%。
壳寡糖,是经该壳聚糖酶水解胶体壳聚糖后制得,其中胶体壳聚糖的浓度不仅仅局限于某一浓度,其浓度区间为0.1%-8%,其中,壳聚糖的脱乙酰度为65%-95%,经酶催化反应后制得的壳寡糖聚合度区间为3-9,其主要聚合度区间为3-5,产物的聚合度区间相对更为集中与稳定。
壳寡糖:化学名β-(1-4)-2-氨基-2-脱氧-D-葡萄糖,是氨基葡萄糖(Glucosamine)通过β-1,4糖苷键连接而成的聚合度为2-10功能性低聚糖,是迄今所发现的唯一天然阳离子碱性多糖,具有水溶性好、粘度低、生物活性高、分子量小、易被机体吸收等特性。由于含有功能性羟基和基团氨基酸,壳寡糖具备比如抗菌性、抗炎、抗氧化的效果,还能够促进动物机体免疫力效果的提升,所以实际应用效果非常好,同时具备良好的降解性,能够大量地应用到食品、药物、医学等多个行业中,应用广泛。而目前酶法或者化学法所制备的壳寡糖一般都是聚合度区间为2-20的壳寡糖,其产物聚合度区间分布广,后续带来一系列的分离纯化的过程。同时研究发现,在聚合度区间为3-7之间时,随着聚合度的升高壳寡糖的生物活性降低。
本发明得到的壳聚糖酶属于糖苷水解酶第46家族,具有较高的催化活性,该酶热稳定性及pH稳定性好,其能够在45℃-60℃、pH5.0-6.0的区间具有高效降解壳聚糖的酶活,最适反应温度为50℃,最适反应pH为6.0,Mg2+、Mn2+对其活性有一定的促进作用,Cu2+、Ca2+、Zn2+、Ba2+、Co2+对其活性有一定的抑制作用,具有较高的经济价值和工业应用前景。
所述重组表达质粒的构建,首先设计带有酶切位点的引物,通过PCR扩增出壳聚糖酶基因csE,ptrc-99a质粒均用XbalI和HindIII进行双酶切,割胶回收的酶切产物通过同源重组的方式进行连接,得到重组质粒ptrc99a-csE,并对重组质粒经酶切鉴定并测序。
所述重组大肠杆菌工程菌的构建,将上述所获得的重组质粒通过化转的方式分别转入大肠杆菌pET-22b、Trans5a、Trans1-T1、Rosetta-gami感受态中,优选地,将重组质粒通过化转的方式转入E.coli Trans1-T1获得重组菌E.coli Trans1-T1/pTrc99a-csE。
所述重组菌的高密度发酵与高效表达,首先将该菌株活化于LB平板培养基(酵母粉5g/L、蛋白胨10g/L、氯化钠10g/L、琼脂粉15g/L)上,于37℃过夜培养后挑取单菌落于LB液体培养基(酵母粉5g/L、蛋白胨10g/L、氯化钠10g/L)中培养16h后按照2%的接种量接种至发酵培养基,其中发酵培养基组成为:酵母粉5g/L,甘油10g/L,蛋白胨15g/L,磷酸氢二钾8g/L,磷酸二氢钾3g/L,硫酸镁0.3g/L,硫酸铵1.2g/L,待其OD600长至0.8时,降温至28℃,加入IPTG使其终浓度为0.3mmol/L,控制溶氧与pH分别为30%、7.0,必要时补充500g/L的葡萄糖溶液作为补充碳源,待其诱导产酶12h后结束发酵后收集菌体破碎得到粗酶液。
包含壳聚糖酶基因的重组大肠杆菌E.coli Trans1-T1/pTrc99a-csE。
有益效果:
1、本发明通过将梭菌属中地壳聚糖酶基因通过PCR的方式获得,并将其重组于大肠杆菌工程菌,获得能够高效表达该基因的重组大肠杆菌工程菌E.coli Trans1-T1/pTrc99a-csE,为新酶的挖掘与应用拓宽了资源。
2、本发明所挖掘的壳聚糖酶,其氨基酸序列如SEQ ID NO:1所示,其与已经报道的壳聚糖酶氨基酸序列最高相似性为34.7%。
3、本发明提供的包含壳聚糖酶基因的重组大肠杆菌E.coli Trans1-T1/pTrc99a-csE,该菌株能够高效表达获得壳聚糖酶,该壳聚糖酶经生物信息学分析表明,该壳聚糖酶属于糖苷水解酶第46家族,具有较高的催化活性,同时经过实验验证,该酶热稳定性及pH稳定性好,最适作用温度为50℃,最适反应pH为6.0,Mg2+、Mn2+对其活性有一定的促进作用,Cu2 +、Ca2+、Zn2+、Co2+对其活性有一定的抑制作用,具有较高的经济价值和工业应用前景。
附图说明
图1是分离自梭菌属的本发明所述壳聚糖酶的最适作用温度;
图2是分离自梭菌属的本发明所述壳聚糖酶的最适作用pH;
图3水解产物液相色谱分析图。
具体实施方式
根据下述实施例,可以更好地理解本发明。
本发明中,重组菌基础培养基组成为:氯化钠10g/L,蛋白胨10g/L,酵母粉5g/L。发酵培养基组成为:酵母粉5g/L,甘油10g/L,蛋白胨15g/L,磷酸氢二钾8g/L,磷酸二氢钾3g/L,硫酸镁0.3g/L,硫酸铵1.2g/L。
本发明中,抗生素的使用浓度为:氯霉素25mg/L,硫酸卡那霉素25mg/L,氨苄青霉素钠100mg/L。
实施例1酶基因的获得及重组质粒的构建
通过NCBI比对结果发现,从草莓根际土壤所筛选的梭菌属菌株具有潜在的壳聚糖酶基因,通过选用诺维赞的细菌基因组DNA提取试剂盒提取该菌株基因组,经NCBI比对后选用具有高度同源性的壳聚糖酶基因作为目标序列,设计引物
csE-F:AGTAAAACAAAGATGAAAAATTTACGA
csF-R:ATAAACATCACCATCATTATTGGGATT
分别以从梭菌属基因组DNA为模板,对其进行目的基因序列csE(SEQ ID NO:2)进行扩增,以从该菌中获得本发明所述壳聚糖酶基因片段。反应体系总体积为50μL,2×TaqMax Master Mix 25μL,质粒模板2μL,上游引物1μL,下游引物1μL,ddH2O 21μL。PCR扩增反应程序为首先94℃预变性3min,然后94℃变性1min、55℃退火1min、72℃延伸1min,总共循环30次,最后72℃终延伸10min。利用SanPreP柱式DNA胶回收试剂盒对PCR反应产物进行胶回收。方法参照试剂盒说明书。随后取3ul回收产物进行琼脂糖凝胶电泳检测(150V,15min),并利用凝胶成像仪观察。将PCR反应回收产物与经双酶切的pTrc99a质粒片段混合,37℃连接30min,冰浴30min,连接体系:3μL载体,1μL PCR回收片段、4μL CE buffer、2μLExnaseⅡ、10μL ddH2O。
实施例2含有该壳聚糖酶基因的重组大肠杆菌工程菌的构建从-80℃冰箱取一管大肠杆菌Trans1-T1(购自诺维赞生物科技有限公司)感受态细胞,置于冰上融化;加入上述连接产物10μL轻轻混匀后冰浴30min;将上述混合物在42℃水浴中热击90s,然后立刻放置于冰上5min;加入800μL LB培养基,37℃培养1h,5000rpm离心10min,除去上清液,重悬沉淀;取适量的上述混合物涂布在LB(含卡那霉素25μg/mL和氯霉素25μg/mL)平板上,37℃倒置过夜培养挑取转化子,后提取质粒PCR验证即获得重组菌E.coli Trans1-T1/pTrc99a-csE。
实施例3壳聚糖酶酶活的测定
(1)壳聚糖酶的高密度诱导表达
将成功转入该壳聚糖酶基因的E.coli Trans1-T1/pTrc99a-csE于37℃LB平板过夜培养,挑取单菌落接种到新鲜LB(含卡那霉素25μg/mL和氯霉素25μg/mL)培养基中,37℃振荡过夜培养。以2%的接种量接种到含卡那霉素和氯霉素的发酵培养基中,其中发酵培养基组成为:酵母粉5g/L,甘油10g/L,蛋白胨15g/L,磷酸氢二钾8g/L,磷酸二氢钾3g/L,硫酸镁0.3g/L,硫酸铵1.2g/L,37℃培养,直到OD600达到0.6-0.8时降低温度至28℃,控制溶氧与pH分别为30%、7.0,加入终浓度为0.3mM的IPTG诱导表达8h后,在低温4℃,8000rpm条件下离心5min收集菌体细胞。随后用生理盐水洗涤3次,用0.2M乙酸-乙酸钠缓冲液(pH 6.0)重悬菌体备用。
(2)粗酶液的制备
用0.2M乙酸-乙酸钠缓冲液(pH 6.0)重悬的细胞在冰浴中用超声破碎仪破碎,脉冲3s,破碎30min。然后在4℃条件下10000rpm离心20min,去除菌体碎片,收集上清液即制得粗酶液。
(3)DNS法测定壳聚糖酶活性
用pH 6.0的醋酸-醋酸钠缓冲溶液配置1%的胶体壳聚糖溶液,于2mL EP中进行反应,反应体系包含30μL稀释的酶液和970μL预热至50℃的1%浓度的壳聚糖溶液,在50℃条件下反应10min,加入1mL DNS溶液终止反应,12000×g条件下离心5min,取上清1mL,100℃水浴5min,迅速冷却后,测量OD540。以氨基葡萄糖作为标样,制作标准曲线。一个酶活单位(U)定义为在上述条件下,每分钟产生相当于1μmol氨基葡萄糖的还原糖量所需的酶量。所述壳聚糖酶在上述最佳条件反映下酶活为16.4U/mL。
实施例4壳聚糖酶的酶学性质及生物活性
将实施例3所获得的粗酶液,分别在30℃至80℃范围内选择温度点(间隔5℃),测定其在不同温度下的酶活力,以最大酶活为100%,以确定该酶的最适作用温度。同时取粗酶液,分别保温于上述不同温度中60min,测定其残存酶活力,以最大酶活为100%,以确定该酶的温度稳定性。
取一定量的粗酶液,分别在pH 3.5-6.0的乙酸钠缓冲液,pH 6.0-8.0的磷酸盐缓冲液中(pH间隔0.5单位)进行反应,测定不同pH下的酶活力,以最大酶活为100%,以确定该酶的最适作用pH。同时取粗酶液分别在pH 3.5-6.0的乙酸钠缓冲液,pH 6.0-8.0的磷酸盐缓冲液中(pH间隔0.5单位)放置60min,回调至pH 6.0后,再测定酶活力,以最大酶活为100%,以确定该酶的pH稳定性。
选择金属离子Mg2+,Mn2+,Cu2+,Ca2+,Zn2+,Co2+,Ba2+,加入反应混合物中,使其浓度分别为5mmol/L,置于4℃1h后按照上述酶活力测定方法测定酶活力。以不加任何金属离子的粗酶液做对照,比较不同金属离子对酶活性的影响,结果见表1。
表1不同金属离子对壳聚糖酶酶活的影响
金属离子 | CK | Mg<sup>2+</sup> | Mn<sup>2+</sup> | Cu<sup>2+</sup> | Ca<sup>2+</sup> | Zn<sup>2+</sup> | Co<sup>2+</sup> | Ba<sup>2+</sup> |
相对酶活(%) | 100 | 108.6 | 126.8 | 76.4 | 74.8 | 68.9 | 89.6 | 64.8 |
由上述实验结果可知,以不添加任何金属离子作为空白对照,Mg2+、Mn2+对其活性有一定的促进作用,其中Mn2+的促进作用较为明显,Cu2+、Ca2+、Zn2+、Co2+对其活性有一定的抑制作用。
实施例5水解产物聚合度分析
将壳聚糖粉末用少量水溶胀后,溶于0.6mol/L的醋酸-醋酸钠缓冲溶液(pH=6.0)中,制成2%的胶体壳聚糖溶液,预热至50℃后按照50U/g壳聚糖的添加量往其中添加粗酶液,恒温水解5h后取样沸水浴10min终止反应,后通过高效液相色谱测定产物聚合度区间。以聚合度为2-10的壳寡糖混标为参考,采用蒸发光散射检测器,Shodex聚乙烯醇氨基柱(NH2P-50 4E),采用梯度洗脱的方式,流动相为乙腈/水(0-30min:70%-60%乙腈;30-50min:60%-50%乙腈;50-60min:50%-70%乙腈),流速为0.6mL/min,柱温30℃,蒸发室温度:50℃,喷雾温度:50℃。
表2水解产物各聚合度占比
聚合度 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
比例(%) | 25.6 | 32.9 | 24.8 | 6.2 | 7.1 | 1.5 | 1.9 |
由以上结果可知,经酶解反应制得的产物聚合度区间为3-9,主要为3-5,产物聚合度区间集中。
实施例6水解产物稳定性实验
A:将壳聚糖粉末用少量水溶胀后,分别溶于0.6mol/L的醋酸-醋酸钠缓冲溶液(pH=5.0、5.5、6.0)中,制成2%的胶体壳聚糖溶液,预热至50℃后按照50U/g壳聚糖的添加量往其中添加粗酶液,恒温水解5h后取样沸水浴10min终止反应,后通过高效液相色谱测定产物聚合度区间。
B:将壳聚糖粉末用少量水溶胀后,分别溶于0.6mol/L的醋酸-醋酸钠缓冲溶液(pH=6.0)中,制成2%的胶体壳聚糖溶液,分别预热至45℃、50℃、55℃后按照50U/g壳聚糖的添加量往其中添加粗酶液,恒温水解5h后取样沸水浴10min终止反应,后通过高效液相色谱测定产物聚合度区间。
表3不同反应条件对产物聚合度的影响
由上表可以得出,该酶在pH5.0-6.0、反应温度45-55℃区间之内,对其水解产物的聚合度无明显影响,证明该酶的性质不随反应条件的改变而改变。
本发明的壳聚糖酶的水解产物聚合度相对比较集中,能特异性水解获得聚合度在3-5之间的壳寡糖。
表4不同反应条件对转化率的影响
由以上结果可以看出,不同水解条件下对水解转化率有一定的影响,但是并未有,而目前酶法生产壳寡糖的过程当中转化率一般都只有70%-80%左右,较低的转化率带来了较为复杂的后续分离纯化的过程,本发明所提供的酶及其在生产壳寡糖上的应用具有明显的优势与较高的应用价值。
序列表
<110> 苏州科宁多元醇有限公司
<120> 一种来源于梭菌属的壳聚糖酶基因及其重组菌和在生产壳寡糖上的应用
<141> 2020-12-28
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 266
<212> PRT
<213> 人工序列(2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 1
Met Lys Asn Leu Arg Lys Leu Val Thr Leu Ala Val Ser Leu Ala Met
1 5 10 15
Cys Leu Ser Phe Cys Ser Ala Ala Leu Ala Ile Thr Ala Asn Ser Glu
20 25 30
Gln Arg Ala Val Ser Leu Gln Leu Ala Thr Val Ser Glu Asn Ser Lys
35 40 45
Thr Lys Phe Val Tyr Asn Tyr Ala Glu Gln Leu Gly Ser Phe Asp Arg
50 55 60
Arg Gly Ile Thr Phe Gly Cys Met Gly Phe Pro Arg Gly Thr Lys Asp
65 70 75 80
Gly Asn Ile Leu Ile His His Tyr Pro Arg Leu Asn Arg Pro Asn Asn
85 90 95
Leu Ala Gln Val Tyr Ser Ser Ile Arg Ser Asn Arg Gln Arg Arg Pro
100 105 110
Ser Arg Gly Trp Asn Ala Arg Arg Tyr Arg Ser Ser Arg Glu Phe Tyr
115 120 125
Ala Arg Cys Lys Val Met Leu Cys Phe Ile Ile Glu Glu Arg Pro Ile
130 135 140
Ile Gly Pro Ser Ser His Val Phe Ser Thr Thr Ser Thr Ser Ser Asn
145 150 155 160
Phe Pro Arg Arg Tyr Thr Ser Thr Asn Phe Ser Ile His Leu Arg Tyr
165 170 175
Val Ser Gln Ser Cys Arg Arg Trp Ser Lys Arg Ile Tyr Gln Ile Gly
180 185 190
Lys Gln Lys Val Arg Trp Ile Thr Glu Gly Trp Tyr Arg Cys Ala Asp
195 200 205
Thr Ser Val Gln Cys Asp Gly Leu Gln Ile Cys Ile Ser Gln Arg Ser
210 215 220
Ser Ser Arg Arg Phe Gly Thr Ser Lys Cys Ile Lys Gln Ile Ile His
225 230 235 240
Ser Ser Ser Cys Arg Phe Glu Thr Arg Leu Ser Phe Tyr Ser Leu Trp
245 250 255
Arg Tyr Phe Gln Tyr Arg Trp Arg Cys Phe
260 265
<210> 2
<211> 801
<212> DNA
<213> 人工序列(2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 2
atgaaaaatt tacgaaaatt agttacttta gcagtatctt tggctatgtg tctctcattc 60
tgttcagcag cattagccat tactgcaaat tctgaacaga gagcagtgtc cctccagtta 120
gcgactgtat ctgaaaacag taaaacaaag tttgtttata attatgcaga gcagcttggc 180
tcctttgatc gacgaggaat tacatttgga tgtatgggat ttcctagagg aactaaggat 240
ggaaatatat taatacatca ttatcctcgg ctaaatcgcc ctaataattt ggcccaagta 300
tattccagca ttagatcgaa tagacaacga agaccatcaa gaggatggaa cgcacgaaga 360
tatagaagct ctagagaatt ttatgcaaga tgtaaagtca tgttatgctt cattattgaa 420
gaacgcccaa ttataggacc ttcatcacat gtattctcaa caaccagtac ctctagcaac 480
ttccctcggc gctacacatc cactaacttt agcattcatt tacgatatgt gtctcaatca 540
tgtagaagat ggagcaaaag aatatatcag atcggcaaac aaaaagttag gtggattacc 600
gaaggatggt atagatgcgc agacacttcg gtccagtgtg atggattaca gatatgcatt 660
tctcaaagat catcatccag aaggttcgga acgagtaaat gcataaagca gattattcac 720
agcagctcat gtagatttga aaccagactt tcattttaca gtttatggag atactttcaa 780
tatagatggc gatgtttcta a 801
<210> 3
<211> 27
<212> DNA
<213> 人工序列(2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 3
agtaaaacaa agatgaaaaa tttacga 27
<210> 4
<211> 27
<212> DNA
<213> 人工序列(2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 4
ataaacatca ccatcattat tgggatt 27
Claims (10)
1.一种来源于梭菌属的壳聚糖酶,其氨基酸序列如SEQ ID NO:1所示。
2.编码权利要求1所述壳聚糖酶的基因,其核苷酸序列如SEQ ID NO:2所示。
3.一种重组质粒,其特征在于,它包含权利要求2所述的壳聚糖酶的基因。
4.一种重组菌,其特征在于,它含有权利要求3所述的重组质粒。
5.壳聚糖酶的制备方法,其特征在于,在营养培养基中培养权利要求4所述的重组菌,收集具有壳聚糖酶活性的多肽。
6.根据权利要求5所述的制备方法,其特征在于,所述营养培养基为酵母粉5.0-7.5 g/L,甘油10.2-12 g/L,蛋白胨11.5-15.0 g/L,磷酸氢二钾6.3-8.6 g/L,磷酸二氢钾1.2-3.0g/L,硫酸镁0.32-0.48 g/L,硫酸铵1.2-2.6 g/L。
7.权利要求1所述壳聚糖酶在生产壳寡糖上的应用。
8.根据权利要求7所述的应用,其特征在于,将壳聚糖酶直接与底物0.1-8%的胶体壳聚糖溶液反应4-8h,即获得壳寡糖。
9.根据权利要求7所述的应用,其特征在于,所制备得到的壳寡糖聚合度区间为3-9,主要分布于3-5,水解效率大于90%。
10.根据权利要求7所述的应用,其特征在于,反应温度为45-55℃,反应pH为5.0-6.0。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011558290.3A CN112746064B (zh) | 2020-12-28 | 2020-12-28 | 一种来源于梭菌属的壳聚糖酶基因及其重组菌和在生产壳寡糖上的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011558290.3A CN112746064B (zh) | 2020-12-28 | 2020-12-28 | 一种来源于梭菌属的壳聚糖酶基因及其重组菌和在生产壳寡糖上的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112746064A CN112746064A (zh) | 2021-05-04 |
CN112746064B true CN112746064B (zh) | 2022-06-17 |
Family
ID=75645902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011558290.3A Active CN112746064B (zh) | 2020-12-28 | 2020-12-28 | 一种来源于梭菌属的壳聚糖酶基因及其重组菌和在生产壳寡糖上的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112746064B (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012305442A1 (en) * | 2011-09-05 | 2014-04-24 | Toray Industries, Inc. | Mutant endoglucanase |
EP3097191A1 (en) * | 2014-01-23 | 2016-11-30 | Novozymes A/S | Variants of gh family 5 endoglucanase and polynucleotides encoding same |
-
2020
- 2020-12-28 CN CN202011558290.3A patent/CN112746064B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112746064A (zh) | 2021-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108285900B (zh) | 一种重组褐藻胶裂解酶及其构建方法及应用 | |
KR102011718B1 (ko) | 해조류로부터 포도당 및 라미나리올리고당을 생산하는 신규한 베타―글루코시데이즈 | |
CN110066777B (zh) | 一种内切菊粉酶及其在生产低聚果糖中的应用 | |
CN106811451B (zh) | 一种低温壳聚糖酶及其编码基因与应用 | |
CN108611337B (zh) | 一种重组壳聚糖酶及其生产方法与应用 | |
CN112111472B (zh) | 一种新型β-木糖苷酶及其制备 | |
CN112725319B (zh) | polyG底物特异性的褐藻胶裂解酶FaAly7及其应用 | |
CN114457057B (zh) | 一种壳聚糖酶突变体及其应用 | |
CN113717963B (zh) | 一种几丁质酶和AfChi18基因及其表达方法与应用 | |
CN113234705B (zh) | 耐酸1,3-1,4-β-葡聚糖酶突变体 | |
CN110951803A (zh) | 组合利用特异性琼胶酶制备高纯度新琼二糖的方法及应用 | |
CN114480350A (zh) | 卡拉胶酶在降解κ-卡拉胶和红藻胶中的应用 | |
CN107603967B (zh) | 一种壳聚糖酶csn4及其编码基因和应用 | |
CN111334488B (zh) | 昆布多糖酶ouc-l1及其编码基因与应用 | |
CN112746064B (zh) | 一种来源于梭菌属的壳聚糖酶基因及其重组菌和在生产壳寡糖上的应用 | |
KR20100040438A (ko) | 신규한 아가레이즈 및 이를 이용한 아가로스로부터 아가로올리고사카라이드의 효소적 생산방법 | |
CN113481186B (zh) | 一种GH18几丁质酶ChiA及其应用 | |
CN113481187B (zh) | 一种褐藻胶裂解酶突变体及其应用 | |
CN115873831A (zh) | 一种高催化活性及温度稳定性的壳聚糖酶突变体及其应用 | |
CN111394344B (zh) | 一种低温耐硫酸盐的透明质酸裂解酶ynlx-hyl及其应用 | |
CN108841805B (zh) | 一种热稳定性提高的脂肪酶突变体 | |
CN112831511B (zh) | 一种外切褐藻胶裂解酶、其编码基因及应用 | |
CN110982831B (zh) | 基因AlgL23具有冷适应性的用途 | |
CN111979218B (zh) | 一种Arthrobacter sp. AW19M34-1几丁质脱乙酰酶突变体 | |
CN118325879B (zh) | 一种褐藻胶裂解酶突变体PL31PtM及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 215000, No. 30 Nanguandu Road, Economic Development Zone, Wuzhong District, Suzhou City, Jiangsu Province Patentee after: Suzhou Koning polyol Co.,Ltd. Country or region after: China Address before: 215000 no.1183 Wuzhong Avenue, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province Patentee before: Suzhou Koning polyol Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |